AIIMS Director, Randeep Guleria while speaking to NDTV answers key questions on the findings of India's sero-survey. Mr Guleria also talks about India's vaccination targets and plans to combat different coronavirus variants. Further, he also sheds light on Pfizer withdrawing emergency use request in India and what that could mean for country's vaccine plan.